DW2008S and its major constituents from Justicia procumbens exert anti‐asthmatic effect via multitargeting activity

Our previous study revealed that the ethanolic extract of Justicia procumbens ameliorates ovalbumin‐induced airway inflammation and airway hyper‐responsiveness in a mouse model of asthma. However, the mechanism of action of the extract remains unknown. In this study, we prepared DW 2008S, an optimized and standardized powder extracted from J. procumbens using anhydrous ethanol, and investigated its anti‐asthmatic effect and mechanism of action. Our results showed that DW 2008S contains two major ingredients, justicidin A ( JA ) and justicidin B ( JB ), which selectively inhibit T helper 2 (Th2) cell responses in concanavalin A‐activated spleen cells and polarized Th2 cells. Blockade of T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine‐based inhibition motif domains ( TIGIT ) using a neutralizing antibody also selectively inhibited Th2 cell responses. Furthermore, DW 2008S regulated TIGIT expression in the mice and cultured cells. Additionally, DW 2008S and JA antagonized human adenosine receptor A 3 (A 3 AR ), which mediates mast cell‐dependent inflammation and bronchoconstriction. DW 2008S and JB inhibited human phosphodiesterase 4 ( PDE 4), which is known to cause bronchoconstriction; however, the required concentrations were higher than those needed to affect TIGIT . These findings suggest that DW 2008S can potentially ameliorate Th2‐driven airway inflammation and bronchoconstriction through negative regulation of TIGIT and blockade of A 3 AR and PDE 4 activities.